SCHEMBL7543848

SCHEMBL7543848

C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 13/20 1.00
DRD2 P14416 11/20 1.00
HTR2A P28223 5/20 1.00
HTT P42858 2/20 1.00
OPRM1 P35372 1/20 0.77
OPRK1 P41145 1/20 0.77
KDM4E B2RXH2 3/20 0.73
LMNA P02545 3/20 0.73
ALOX15 P16050 3/20 0.73
SLC6A4 P31645 2/20 0.62
POLB P06746 1/20 0.62
HTR6 P50406 1/20 0.62
HSD17B10 Q99714 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
SIGMAR1 Q99720 1/20 0.61
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
TDO2 P48775 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13944353 0.89 DRD2 (0.79) HTR1ADRD2HTR2AHTTOPRM1
SCHEMBL11329993 0.88 HTR1A (0.78) HTR1ADRD2HTR2AHTTOPRM1
Hydrochloric Acid SCHEMBL11318644 0.88 HTR1A (0.78) HTR1ADRD2HTR2AHTTOPRM1
SCHEMBL14280720 0.87 OPRM1 (1.00) HTR1ADRD2HTR2AHTTOPRM1
SCHEMBL1719798 0.86 DRD2 (0.76) HTR1ADRD2HTR2AHTTOPRM1
SCHEMBL7536094 0.86 OPRM1 (0.78) HTR1ADRD2HTR2AHTTOPRM1
SCHEMBL9527241 0.86 OPRM1 (0.78) HTR1ADRD2HTR2AHTTOPRM1
SCHEMBL11321052 0.84 KDM4E (1.00) HTR1ADRD2HTR2AHTTOPRM1
Hydrochloric Acid SCHEMBL11325899 0.84 KDM4E (1.00) HTR1ADRD2HTR2AHTTOPRM1
SCHEMBL4469442 0.84 KDM4E (0.76) HTR1ADRD2HTR2AHTTOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037635-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2002-11-13 EP claimed
US-6476028-B1 Compounds and methods SMITHKLINE BEECHAM CORPORATION 2002-11-05 US claimed
EP-1037635-A1 COMPOUNDS AND METHODS Smithkline Beecham (US) 2000-09-27 EP claimed
WO-1999017773-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 1999-04-15 WO claimed
CN-102796075-B Benzocycloheptenes derivative as well as preparation method and medical application thereof INST PHARM & TOXICOLOGY AMMS 2014-03-12 CN disclosed
CN-101481323-B Benzocycloheptenes derivatives, preparation method and medical application thereof POISON MED INST PLA MED ACAD 2013-11-20 CN disclosed
CN-102796075-A Benzocycloheptenes derivative as well as preparation method and medical application thereof INST PHARM & TOXICOLOGY AMMS 2012-11-28 CN disclosed
CN-101481323-A Benzocycloheptenes derivatives, preparation method and medical application thereof POISON MED INST PLA MED ACAD (CN) 2009-07-15 CN disclosed
EP-1037635-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2002-11-13 EP disclosed
US-6476028-B1 Compounds and methods SMITHKLINE BEECHAM CORPORATION 2002-11-05 US disclosed
EP-1037635-A1 COMPOUNDS AND METHODS Smithkline Beecham (US) 2000-09-27 EP disclosed
WO-1999017773-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 1999-04-15 WO disclosed
US-3947578-A Omega-[4-(3\"-indolyl)-piperidino]-alkyl-arylketones as nevroleptics ROUSSEL UCLAF (FR) 1976-03-30 US disclosed